Clinical trial
A Trial to Assess Campath-1H and Tacrolimus Followed by Immunosuppression…
NCT00166556 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00166556 |
|---|---|
| Title | A Trial to Assess Campath-1H and Tacrolimus Followed by Immunosuppression Withdrawal in Liver Transplantation |
| Official title | Thistlethwaite Protocol # ITN025ST - Immunosuppression With Campath-1H and Tacrolimus in Liver Transplantation |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | University of Chicago Immune Tolerance Network (ITN) |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Transplantation, Liver |
| Intervention type | Drug |
| Interventions | Campath-1H and Tacrolimus |
| Enrollment | 10 |
| Start date | Jan 1, 2005 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Sep 14, 2005 |
| Last update posted | May 23, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: